Alkermes plc - חוב לטווח קצר של החברה ALKS

Alkermes plc (ALKS) maintains strong stock quotes due to its high authority in addiction treatment. The short-term liabilities indicator visualizes liquidity dynamics, where the value of 0.00 corresponds to the current metric. Revenues are based on settlements with US insurance companies for complex injections. Supply efficiency is ensured through plant diversification and strict control of logistics routes, which minimizes shortage risks.

To assess the fundamental stability of Alkermes plc (ALKS), it is critical to monitor the aggregate of liabilities maturing within one year, which reflects current debt on loans and borrowings. A reduction in this metric minimizes liquidity risk, allowing the company to direct high margins from the sale of patented drugs toward scaling production and the effective utilization of operating leverage.